First Trust Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-8,910
| Closed | -$404K | – | 2356 |
|
|
2023
Q3 | $404K | Sell |
8,910
-87,488
| -91% | -$3.97M | ﹤0.01% | 2190 |
|
|
2023
Q2 | $5.41M | Buy |
+96,398
| New | +$5.41M | 0.01% | 1196 |
|
|
2023
Q1 | – | Sell |
-6,238
| Closed | -$254K | – | 2379 |
|
|
2022
Q4 | $254K | Sell |
6,238
-55,307
| -90% | -$2.25M | ﹤0.01% | 2334 |
|
|
2022
Q3 | $4.02M | Buy |
61,545
+52,930
| +614% | +$3.46M | 0.01% | 1311 |
|
|
2022
Q2 | $524K | Buy |
8,615
+232
| +3% | +$14.1K | ﹤0.01% | 2187 |
|
|
2022
Q1 | $526K | Buy |
8,383
+1,556
| +23% | +$97.6K | ﹤0.01% | 2241 |
|
|
2021
Q4 | $517K | Sell |
6,827
-35,470
| -84% | -$2.69M | ﹤0.01% | 2283 |
|
|
2021
Q3 | $4.73M | Buy |
+42,297
| New | +$4.73M | 0.01% | 1351 |
|
|
2021
Q2 | – | Sell |
-30,979
| Closed | -$3.78M | – | 2493 |
|
|
2021
Q1 | $3.78M | Sell |
30,979
-34,023
| -52% | -$4.15M | ﹤0.01% | 1410 |
|
|
2020
Q4 | $9.95M | Sell |
65,002
-1,309
| -2% | -$200K | 0.01% | 830 |
|
|
2020
Q3 | $5.55M | Sell |
66,311
-3,098
| -4% | -$259K | 0.01% | 921 |
|
|
2020
Q2 | $5.1M | Sell |
69,409
-21,724
| -24% | -$1.6M | 0.01% | 977 |
|
|
2020
Q1 | $3.87M | Buy |
+91,133
| New | +$3.87M | 0.01% | 966 |
|
|
2019
Q4 | – | Sell |
-24,085
| Closed | -$987K | – | 2398 |
|
|
2019
Q3 | $987K | Buy |
+24,085
| New | +$987K | ﹤0.01% | 1875 |
|
|
2019
Q2 | – | Sell |
-24,892
| Closed | -$889K | – | 2437 |
|
|
2019
Q1 | $889K | Sell |
24,892
-8,977
| -27% | -$321K | ﹤0.01% | 1908 |
|
|
2018
Q4 | $968K | Sell |
33,869
-59,478
| -64% | -$1.7M | ﹤0.01% | 1843 |
|
|
2018
Q3 | $4.14M | Buy |
93,347
+8,295
| +10% | +$368K | 0.01% | 1248 |
|
|
2018
Q2 | $5M | Buy |
+85,052
| New | +$5M | 0.01% | 1098 |
|